News : Life @ MINATEC

December 05 2016

Emmanuelle Gourieux, active in student life

  • Education
  • Life @ MINATEC
  • News
Emmanuelle Gourieux, a third-year student at Grenoble Institute of Technology’s Phelma engineering school, has been elected Student Vice President. She will represent her cohort to Grenoble Institute of Technology and sit on several commissions, including CSIE*, which she co-chairs and which provides financial support for student non-profit initiatives. Emmanuelle also represents her classmates to the […] >>

December 05 2016

Interview: Anna Choulier Renström, Leti

  • Industry
  • Innovation & Society
  • Interviews
  • Life @ MINATEC
What is Leti’s strategy for CES 2017? Our booth will be twice as big as last year’s. We will showcase three interactive demonstrator systems that will let visitors experience and test our technologies and understand the technologies’ features. Three startups will be coming with us: e-Lichens, with us in 2016; Moovlab, which was just created; […] >>

December 05 2016

Israeli teachers at CIME

  • Education
  • Life @ MINATEC
  • News
As part of the EU EduNano project, eight Israeli high-school teachers will come to CIME Nanotech in mid-December to expand their knowledge and discuss teaching methods with the Nano@school team. The program includes nano-biotech, atomic force microscopy, and PV characterization lab classes and even classes taught right in the clean room! In July, CIME hosted […] >>

December 05 2016

Photonics platform delivery date pushed back

  • Life @ MINATEC
  • News
Delivery of the six-level, 12,800 sq. m photonics platform was originally scheduled for early November, but has been pushed back to January due to construction delays and the results of certain tests. The contractor that won the bid will have to put additional resources on the job to complete construction. The CEA has set up […] >>

December 05 2016

PX’Therapeutics focuses on new drug candidate

  • Industry
  • Life @ MINATEC
  • MINATEC
  • News
  • Research
In the future, diabetics suffering from neuropathy (in their hands and feet, for example) could benefit from a new drug called atexakin, which regenerates damaged nerve fibers. Switzerland’s Relief Therapeutics Holding AG recently signed an agreement with Merck to develop, manufacture, and commercialize the drug. Merck then turned to Grenoble’s PX’Therapeutics to develop an efficient […] >>
More information
X